Antibody - Plato Data Intelligence

IPA Announces Closing of $1.265 Million Public Offering of Common Shares

FintechDecember 8, 2023

VICTORIA, British Columbia–(BUSINESS WIRE)–$IPA #AI–ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (“ImmunoPrecise” or “IPA” or the “Company”), today announced the closing of its $1.265 million underwritten...

AstraZeneca bets $247m AI can create cancer antibody

AIDecember 4, 2023

Pharma giant AstraZeneca has signed a $247 million deal with Ai drug creation company Absci to develop an antibody designed to fight cancer. The collaboration...

Boehringer Ingelheim signs up with IBM for AI therapy

AIDecember 1, 2023

Boehringer Ingelheim is the latest pharma company to turn to AI in the hunt for new treatments and therapies. The German company announced earlier this...

Nanomaterials in Personalized Medicine Global Markets Report 2023: Trends and Data from 2020-2023 and CAGR Projections through 2028 – ResearchAndMarkets.com

FintechNovember 18, 2023

DUBLIN–(BUSINESS WIRE)–The “Nanomaterials in Personalized Medicine: Global Markets” report has been added to ResearchAndMarkets.com’s offering. The global market for nanomaterials in personalized medicine was valued...

How Generative AI Could Help Us Predict the Next Pandemic

AINovember 13, 2023

Viruses have an uncanny ability to rapidly evolve. Covid-19 is a stark example. As the virus mutated from beta to delta to omicron, the...

Total-body PET imaging reveals immune response in COVID-19 patients – Physics World

QuantumNovember 7, 2023

Understanding how the body’s immune system responds to viral infections is essential for developing new vaccines and improved treatments. The recent...

China Pharmaceutical Competitive Landscape and Drugs Pipeline Analysis Report 2023: Business Overview of 330 Companies, 1500 Drugs in Trials, & 200 Commercially Approved Drugs...

FintechNovember 3, 2023

DUBLIN–(BUSINESS WIRE)–The “China Pharmaceutical Companies and Drugs Pipeline Insight 2023” drug pipelines has been added to ResearchAndMarkets.com’s offering. Chinese drugs makers have advanced significantly in...

Shaperon Inc. Makes a Splash at BioFuture™ 2023 With the Announcement of US Subsidiary Hudson Therapeutics Inc. and Positive Clinical Data

FintechOctober 14, 2023

CAMBRIDGE, Mass. & SEOUL, South Korea–(BUSINESS WIRE)–Shaperon Inc. grabbed the spotlight at BioFuture™ 2023 as it confidently graced the stage, delivering a compelling company...

New Phase 1 Dose Escalation Cohorts Data for Aulos Bioscience’s AU-007 Show Favorable Pharmacodynamic Effects at 2023 AACR-NCI-EORTC International Conference on Molecular Targets and...

FintechOctober 14, 2023

Interim data from an ongoing trial support overall mechanism of action of AU-007, a computationally designed human monoclonal antibody, in decreasing Tregs while increasing...